Search
  • Julie Collorafi

Government Funding of Most Fetal Research Projects Continued Despite Trump Administration Ban

An eye-opening 2019 article in Science magazine confirms that, despite Trump's much-vaunted ban on fetal tissue research, "critical" NIH projects using aborted baby organs continued.


The article reports that Kim Hasenkrug, the director of NIH Rocky Mountain Labs in Montana, appealed to Larry Tabak, deputy director of the NIH, when his BLT mouse experiment was halted due to the Trump Administration cancellation of the federal government's contract with Advanced Bioscience Resources on September 25, 2018.


The day before, on September 24, 2018, the Department of Health and Human Services ordered a review of all US government-funded research that used aborted baby organs.


At a Congressional hearing three months later, in December, 2018, NIH Director Francis Collins defended human fetal tissue research as "scientifically and ethically justified." The NIH would fund research into alternatives, but fetal tissue would remain the "mainstay."


At a December, 13, 2018, advisory committee meeting, in comments made to the press, Larry Tabak personally took the blame for the disruption of Kim Hasenkrug's BLT mouse experiment, saying it had resulted from a "miscommunication." He didn't realize there was an immediate need for new tissue. "There was never an intent to impede," he stated.


Addressing the issue of Hasenkrug's work being interrupted by the cancellation of the ABR contract, Larry Tabak promised that, "We're looking at ways to address that,"meaning they were looking for a new aborted baby organ provider to replace ABR.


Apparently, according to the Science article, the NIH found another fetal tissue provider for the scientists at Rocky Mountain Lab who happily reported, "Our studies are back on track, thanks to the efforts of the NIH."


The Science article revealed that the review process put in place by Brett Giroir at the HHS reduced fetal tissue projects by a paltry $8 million: "NIH estimates it will spend $95 million on projects involving human fetal tissue this year, down from an estimated $103 million in 2018."


It would appear that Kim Hasenkrug's BLT mouse project at Rocky Mountain Labs and also the SCID-hu mouse projects at the University of California San Francisco suffered minor delays but were quickly resumed with fetal tissue supplied under a new contract with another aborted baby organ trafficking agency.


Of course, the Biden Administration ended the Trump Administration's slight restriction on government-funded fetal tissue research, and it is now all-systems-go at the NIH.


This information is an essential backdrop to the "human lung mice" discussions in the Fauci emails. For starters, it reveals the relationship between Kim Hasenkrug and Larry Tabak. Kim Hasenkrug knew Larry Tabak was an ally and would help him with future BLT mouse projects and explains why Kim Hasenkrug sent Larry Tabak an email on February 19, 2020, entitled "SARS-CoV2 in humanized mice," which we know was an appeal for permission to take several dozen human lung mice from researchers at the University of North Carolina as explained in a previous article.



Next, it reveals the ideological divide between the major players in the "human lung mice" discussions in the Fauci emails: Francis Collins, Larry Tabak, Anthony Fauci vs. Brett Giroir---a tension which can be seen in this March 2, 2020, email. Francis, Larry and Tony agree on the matter in the redacted box, but Brett obviously does not.

Francis: Larry has it right. Tony may want to add.

Tony: Ditto




Lastly, it confirms that the HHS has the final say on fetal tissue research, and Brett Giroir was reviewing each experiment---but he also apparently approved the ongoing projects in 2018.


Fauci says on March 1: "Lease [sic] the decision up to HHS."

We don't know what that decision was, but it appears to have been about Kim Hasenkrug taking several dozen leftover BLT-L mice (engrafted with fetal liver, thymus and lung) from the University of North Carolina for use at the Rocky Mountain Labs as discussed in this article.


It seems that a compromise decision was made: Rocky Mountain Labs in Montana was not allowed to become a BLT-L mouse manufacturing facility, but the operation was moved to Canada instead.


There should be a Congressional investigation of the "human lung mice" discussion in the Fauci emails. The American public needs to know more about Ralph Baric's gruesome BLT-L mouse and what role it played in the COVID-19 pandemic.





85 views2 comments